Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Small heterodimer partner (SHP) links hepatitis C and liver fibrosis: a small protein on the big stage — Ralf Weiskirchen (2015) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Small heterodimer partner (SHP) links hepatitis C and liver fibrosis: a small protein on the big stage
RW
Shared by
Ralf Weiskirchen
Small heterodimer partner (SHP) links hepatitis C and liver fibrosis: a small protein on the big stage
Letter
2015
en
Authors
RW
Ralf Weiskirchen
FT
Frank Tacke
Abstract
Related publications
Letter
2017
Combining <scp>GP</scp>73 with liver stiffness measurements: A proof‐of‐concept for non‐invasive fibrosis assessment in antiviral‐naïve <scp>HBV</scp> patients
Ralf Weiskirchen
,
Frank Tacke
Letter
2019
Liver enzymes and all‐cause mortality: Open issues
Federica Turati
,
Carlo La Vecchia
1 min read
See Article on Page 2233
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2006
The fraktalkine receptor CX3CR1 is associated with progression of liver fibrosis in patients with chronic hepatitis C
David Scholten
,
Edgar Dahl
,
Thomas Berg
,
Claus Hellerbrand
,
S Hillebrandt
,
Ralf Weiskirchen
,
Christian Trautwein
,
Frank Lammert
,
HE Wasmuth
Article
2006
Identification of the chemokine CXCL9 (MIG) as a genetic modifier of liver fibrosis in patients with hepatitis C
HE Wasmuth
,
T. Wiederholt
,
Edgar Dahl
,
Claus Hellerbrand
,
Juliane Halangk
,
Timo K. van den Berg
,
S Hillebrandt
,
Danny J. Scholten
,
Ralf Weiskirchen
,
Christian Trautwein
,
Frank Lammert
Letter
2017
Therapeutic targeting of the mitochondrial reactive oxygen species engine prevents portal hypertension and hepatic fibrogenesis
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.